Atai Life Sciences
Series D+Atai Life Sciences raised €131M in a Series D+ round in Mar 2021. The company is based in Munich, Germany. Investors in the round: Apeiron Investment Group, Thiel Capital, Woodline Partners. Data as of 4 Nov 2026.
Amount raised
€131M
€130,528,766
Native amount
157,000,000 USD
Stage
Series D+
series d
Investors
3
Provenance & confidence
High confidenceAmount
157,000,000 USD
ECB-at-date → €131M · rate 1.2028 on 2021-03-02
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
Mar 2021
Round type
series d
Amount (EUR)
€131M